Contact
Please use this form to send email to PR contact of this press release:
Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment and Study Updates for Lead Investigational Gene Therapy
TO:
Please use this form to send email to PR contact of this press release:
Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment and Study Updates for Lead Investigational Gene Therapy
TO: